| LM ID |
Analyte |
Treatment |
Time(hrs) |
Sample ID |
Value |
Units |
| LMFA01030159 |
11,14,17-eicosatrienoic acid |
Lipid-depleted/compactin |
0.0 |
BCD100322A002 |
8.51 |
pmol/sample |
| LMFA01030159 |
11,14,17-eicosatrienoic acid |
Lipid-depleted/compactin |
0.5 |
BCD100322A005 |
10.1 |
pmol/sample |
| LMFA01030159 |
11,14,17-eicosatrienoic acid |
Lipid-depleted/compactin |
1.0 |
BCD100322A009 |
8.16 |
pmol/sample |
| LMFA01030159 |
11,14,17-eicosatrienoic acid |
Lipid-depleted/compactin |
2.0 |
BCD100322A013 |
15.3 |
pmol/sample |
| LMFA01030159 |
11,14,17-eicosatrienoic acid |
Lipid-depleted/compactin |
4.0 |
BCD100322A017 |
15.4 |
pmol/sample |
| LMFA01030159 |
11,14,17-eicosatrienoic acid |
Lipid-depleted/compactin |
8.0 |
BCD100322A021 |
16.2 |
pmol/sample |
| LMFA01030159 |
11,14,17-eicosatrienoic acid |
Lipid-depleted/compactin |
12.0 |
BCD100322A025 |
16 |
pmol/sample |
| LMFA01030159 |
11,14,17-eicosatrienoic acid |
Lipid-depleted/compactin |
24.0 |
BCD100322A029 |
40.6 |
pmol/sample |
| LMFA01030159 |
11,14,17-eicosatrienoic acid |
C |
0.0 |
BCD100322A001 |
7.88 |
pmol/sample |
| LMFA01030159 |
11,14,17-eicosatrienoic acid |
C |
0.5 |
BCD100322A003 |
5.87 |
pmol/sample |
| LMFA01030159 |
11,14,17-eicosatrienoic acid |
C |
1.0 |
BCD100322A007 |
10.6 |
pmol/sample |
| LMFA01030159 |
11,14,17-eicosatrienoic acid |
C |
2.0 |
BCD100322A011 |
9.92 |
pmol/sample |
| LMFA01030159 |
11,14,17-eicosatrienoic acid |
C |
4.0 |
BCD100322A015 |
9.87 |
pmol/sample |
| LMFA01030159 |
11,14,17-eicosatrienoic acid |
C |
8.0 |
BCD100322A019 |
14.4 |
pmol/sample |
| LMFA01030159 |
11,14,17-eicosatrienoic acid |
C |
12.0 |
BCD100322A023 |
32.4 |
pmol/sample |
| LMFA01030159 |
11,14,17-eicosatrienoic acid |
C |
24.0 |
BCD100322A027 |
35.7 |
pmol/sample |
| LMFA01030159 |
11,14,17-eicosatrienoic acid |
25OH-Chol + Lipid-depleted/compactin |
0.5 |
BCD100322A006 |
12.8 |
pmol/sample |
| LMFA01030159 |
11,14,17-eicosatrienoic acid |
25OH-Chol + Lipid-depleted/compactin |
1.0 |
BCD100322A010 |
7.48 |
pmol/sample |
| LMFA01030159 |
11,14,17-eicosatrienoic acid |
25OH-Chol + Lipid-depleted/compactin |
2.0 |
BCD100322A014 |
10.8 |
pmol/sample |
| LMFA01030159 |
11,14,17-eicosatrienoic acid |
25OH-Chol + Lipid-depleted/compactin |
4.0 |
BCD100322A018 |
13.7 |
pmol/sample |
| LMFA01030159 |
11,14,17-eicosatrienoic acid |
25OH-Chol + Lipid-depleted/compactin |
8.0 |
BCD100322A022 |
13.4 |
pmol/sample |
| LMFA01030159 |
11,14,17-eicosatrienoic acid |
25OH-Chol + Lipid-depleted/compactin |
12.0 |
BCD100322A026 |
11.8 |
pmol/sample |
| LMFA01030159 |
11,14,17-eicosatrienoic acid |
25OH-Chol + Lipid-depleted/compactin |
24.0 |
BCD100322A030 |
23.7 |
pmol/sample |
| LMFA01030159 |
11,14,17-eicosatrienoic acid |
25OH-Chol |
0.5 |
BCD100322A004 |
4.04 |
pmol/sample |
| LMFA01030159 |
11,14,17-eicosatrienoic acid |
25OH-Chol |
1.0 |
BCD100322A008 |
6.39 |
pmol/sample |
| LMFA01030159 |
11,14,17-eicosatrienoic acid |
25OH-Chol |
2.0 |
BCD100322A012 |
6.9 |
pmol/sample |
| LMFA01030159 |
11,14,17-eicosatrienoic acid |
25OH-Chol |
4.0 |
BCD100322A016 |
13.1 |
pmol/sample |
| LMFA01030159 |
11,14,17-eicosatrienoic acid |
25OH-Chol |
8.0 |
BCD100322A020 |
7.48 |
pmol/sample |
| LMFA01030159 |
11,14,17-eicosatrienoic acid |
25OH-Chol |
12.0 |
BCD100322A024 |
17.6 |
pmol/sample |
| LMFA01030159 |
11,14,17-eicosatrienoic acid |
25OH-Chol |
24.0 |
BCD100322A028 |
19.8 |
pmol/sample |